CN100479859C - 一种针对靶的空间变构现象筛选可抑制和/或激活所述靶生物活性的物质的方法 - Google Patents
一种针对靶的空间变构现象筛选可抑制和/或激活所述靶生物活性的物质的方法 Download PDFInfo
- Publication number
- CN100479859C CN100479859C CNB021044821A CN02104482A CN100479859C CN 100479859 C CN100479859 C CN 100479859C CN B021044821 A CNB021044821 A CN B021044821A CN 02104482 A CN02104482 A CN 02104482A CN 100479859 C CN100479859 C CN 100479859C
- Authority
- CN
- China
- Prior art keywords
- target
- allosteric
- virus
- monoclonal antibody
- space
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021044821A CN100479859C (zh) | 2002-03-20 | 2002-03-20 | 一种针对靶的空间变构现象筛选可抑制和/或激活所述靶生物活性的物质的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021044821A CN100479859C (zh) | 2002-03-20 | 2002-03-20 | 一种针对靶的空间变构现象筛选可抑制和/或激活所述靶生物活性的物质的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1444995A CN1444995A (zh) | 2003-10-01 |
CN100479859C true CN100479859C (zh) | 2009-04-22 |
Family
ID=27810895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021044821A Expired - Fee Related CN100479859C (zh) | 2002-03-20 | 2002-03-20 | 一种针对靶的空间变构现象筛选可抑制和/或激活所述靶生物活性的物质的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100479859C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0900425D0 (en) * | 2009-01-12 | 2009-02-11 | Ucb Pharma Sa | Biological products |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204096A (en) * | 1984-03-07 | 1993-04-20 | New York Blood Center, Inc. | Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
EP0589004A1 (en) * | 1992-03-06 | 1994-03-30 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
-
2002
- 2002-03-20 CN CNB021044821A patent/CN100479859C/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204096A (en) * | 1984-03-07 | 1993-04-20 | New York Blood Center, Inc. | Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
EP0589004A1 (en) * | 1992-03-06 | 1994-03-30 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
Non-Patent Citations (2)
Title |
---|
人神经生长因子的单克隆抗体制备及抗原决定簇的研究. 林梵等.大连大学学报,第22卷第2期. 2001 |
人神经生长因子的单克隆抗体制备及抗原决定簇的研究. 林梵等.大连大学学报,第22卷第2期. 2001 * |
Also Published As
Publication number | Publication date |
---|---|
CN1444995A (zh) | 2003-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Burton et al. | Broadly neutralizing antibodies to HIV and their role in vaccine design | |
Graham et al. | Structure-based vaccine antigen design | |
Wang et al. | The conformational states of the HIV-1 envelope glycoproteins | |
Feng et al. | Naked viruses that aren't always naked: quasi-enveloped agents of acute hepatitis | |
Gorny et al. | Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades | |
Nara et al. | Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses | |
Xia et al. | Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein | |
Scharf et al. | Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1 | |
Klasse et al. | How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development? | |
Netter et al. | Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes | |
Moore et al. | Specificity of the autologous neutralizing antibody response | |
US5230998A (en) | Method for the prescreening of drugs targeted to the V3 hypervariable loop of the HIV-1 envelope glycoprotein gp 120 | |
Agrawal-Gamse et al. | Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans | |
Logan et al. | Native folding of a recombinant gpE1/gpE2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG | |
Tran et al. | Mapping of ebolavirus neutralization by monoclonal antibodies in the ZMapp cocktail using cryo-electron tomography and studies of cellular entry | |
Favorov et al. | Enzyme immunoassay for the detection of antibody to hepatitis E virus based on synthetic peptides | |
Glamann et al. | Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque | |
Sette et al. | Inducing broad-based immunity against viruses with pandemic potential | |
JPH11506328A (ja) | 単離された、プロセシングされていないポリペプチドを使用するプラス鎖rnaウイルスの診断およびプラス鎖rnaウイルスに対するワクチン接種 | |
Tolaymat et al. | Parvovirus glomerulonephritis in a patient with sickle cell disease | |
Klasse et al. | Patterns of antibodies to human immunodeficiency virus proteins in different subclasses of IgG | |
US7413741B2 (en) | HCV E1 comprising specific disulfide bridges | |
CN100479859C (zh) | 一种针对靶的空间变构现象筛选可抑制和/或激活所述靶生物活性的物质的方法 | |
Liu et al. | Altering the Specificity of the Antibody Response to HIV gp120 with a Glycoconjugate Antigen | |
JPH02203793A (ja) | ヒト免疫不全ウイルスタイプ1のエンベロープ遺伝子から誘導されたポリペプチドを含むワクチン |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20071228 Address after: Postal code No. 422, Siming South Road, Siming District, Xiamen, Fujian, China: 361005 Applicant after: Xiamen University Co-applicant after: Beijing Wantai Biological Pharmaceutical Co., Ltd. Address before: Postal code No. 422, Siming South Road, Siming District, Xiamen, Fujian, China: 361005 Applicant before: Xiamen University Co-applicant before: Yangshengtang Co., Ltd |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20031001 Assignee: BEIJING CONTROLS & STANDARDS BIOTECHNOLOGY CO., LTD. Assignor: Beijing Wantai biological pharmacy Limited by Share Ltd|Xiamen University Contract record no.: 2013990000011 Denomination of invention: Method for filtering out matters possible to restrain and/or activate target biological activity in a iming at phenomena of spatial allosterism of the target Granted publication date: 20090422 License type: Exclusive License Record date: 20130109 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090422 Termination date: 20210320 |